The co-chairs of Mass General Neuroscience are, from left, Merit Cudkowicz, MD, MsC, chief of Neurology; Jerrold Rosenbaum, MD, chief of Psychiatry; Bob Carter, MD, PhD, chief of Neurosurgery.

Mass General Launches Neuroscience Initiative...

Published 3 weeks ago by Terri Ogan in Neurology, Patient Care, Psychiatry

This new initiative called Mass General Neuroscience was created to simplify the patient experience and offer access to the most advanced research and clinical trials.

Henry McCance (center) with (from left) Peter L. Slavin, MD, president, Mass General; Merit Cudkowicz, MD, chief of Neurology; Jonathan Rosand, MD, chief of the Division of Neurocritical Care and Emergency Neurology; Rudolph Tanzi, PhD, director of the Genetics and Aging Research Unit in Mass General Institute for Neurodegenerative Disease; Jerrold Rosenbaum, MD, chief of Psychiatry, and Gregory Fricchione, MD, director of the Benson-Henry Institute for Mind Body Medicine.

McCance Center Promotes Lifetime of Brain Health...

Published 2 months ago by Kay Cahill in Donor Recognition, Neurology

With insights acquired through a lifetime of venture capital investing, Henry McCance is fueling collaboration among top brain scientists and clinicians from across multiple disciplines at the new Henry and Allison McCance Center for Brain Health.

Event Highlights Progress on Brain Disease Research...

Published 4 months ago by Terry Byrne in Medical Research, Neurology

Researchers from the MassGeneral Institute for Neurodegenerative Diseases (MIND) detailed some of the latest advances in brain disease research at MIND’s 2018 Visiting Day.

At Mass General's sixth Annual Stroke Breakfast Gala, Gaspar “Bud” Interrante (pictured with his wife) thanked caregivers for helping him recover from a stroke.

Stroke Patient Says “Amazing Staff” Saved His Life...

Published 4 months ago by Terri Ogan in Neurology, Patient Care, Stroke

A grateful stroke patient from Methuen, Massachusetts says the swift work of his expert Mass General care team allowed him to return home to enjoy his family, including a new granddaughter.

ALS: Rare Form of Disease Studied for Clues...

Published 4 months ago by Brian Burns in Medical Research, Neurology

A Mass General researcher is studying a rare, inherited form of ALS, aiming to diagnose the disease in its earliest stages and develop new treatments.

Multiple sclerosis is a disease of the central nervous system.

Multiple Sclerosis Care Advances but Work Remains...

Published 6 months ago by Brian Burns in Medical Research, Neurology

A clinician-investigator from Mass General’s Multiple Sclerosis Clinic discusses treatment options for MS patients and how research could help in diagnosing and monitoring the disease.

Neurofibromin 1, is a protein that in humans is encoded by the NF1 gene. Mutations in the NF1 gene are associated with neurofibromatosis Type 1 .

Neurofibromatosis Research Reflects Clinic-Lab Link...

Published 7 months ago by Brian Burns in Medical Research, Neurology, Patient Care

At Mass General, Scott Plotkin, MD, PhD, and Vijaya Ramesh, PhD, are using their respective expertise in clinical and fundamental science to investigate new treatments for neurofibromatosis and two related disorders.

Recent breakthrough research into the cause of a rare movement disorder involved, from left, Nutan Sharma, MD, PhD; Cristopher Bragg, PhD; Michael Talkowski, PhD and Laurie Ozelius, PhD.

Philanthropy Fuels Movement Disorder Breakthrough...

Published 7 months ago by Terry Byrne in Medical Research, Neurology

Donor commitment allows rare disease research breakthrough, providing insights into Parkinson’s and other movement disorder diseases.

Cerebral adrenoleukodystrophy (ALD) is a rare disease that destroys the protective sheathing around neurons in the brain like these, leading to paralysis and eventual death if untreated.

Rare Diseases: Collaboration Key to Mass General Advances...

Published 8 months ago by Brian Burns in Medical Research, Neurology

Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.

Predicting the exact cause and time of a migraine attack has proven difficult.

Migraine: Research Model Aims to Predict Attacks...

Published 12 months ago by Joelle Zaslow in Medical Research, Neurology

Mass General researchers have developed a forecasting model for predicting future migraine attacks based on current levels of stress and head pain.

Get Email Updates

Posts Archive

Neurology